Control of autophagy with small molecules

Arch Pharm Res. 2010 Dec;33(12):1881-9. doi: 10.1007/s12272-010-1201-6. Epub 2010 Dec 30.

Abstract

Autophagy is the mass degradation system that removes long-lived proteins and malfunctioning organelles within the cell. Dysfunctional autophagic processes can cause various diseases such as cancer and neurodegenerative disorders, but the underlying mechanisms responsible for such events remain undefined. Small molecules that control autophagy could be powerful tools to reveal autophagy mechanisms, and to develop treatments for autophagy-related diseases including Alzheimer's disease, Parkinson's disease and various cancer types. This review discusses the small molecules that have been identified to control autophagy and how they can be used to understand signaling pathways important for autophagy in the context of chemical genomics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / physiopathology
  • Autophagy / drug effects*
  • Cell Death / drug effects*
  • Humans
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / physiopathology*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology
  • Proteins / metabolism
  • Pyrimidinones / chemistry
  • Pyrimidinones / pharmacology*
  • Signal Transduction / drug effects*
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology*
  • Structure-Activity Relationship
  • Thiophenes / chemistry
  • Thiophenes / pharmacology*

Substances

  • 2-(3-benzyl-4-oxo-3,4,5,6,7,8-hexahydrobenzo(4,5)thieno(2,3-d)pyrimidin-2-ylsulfanylmethyl)-oxazole-4-carboxylic acid (2-pyrrolidin-1-yl-ethyl)amide
  • Proteins
  • Pyrimidinones
  • Small Molecule Libraries
  • Thiophenes